Skip to Main Content

Author Details

Pavel Strop
Pfizer Inc.
1997
72
35
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36791402Residue-Level Characterization of Antibody Binding Epitopes Using Carbene Chemical Footprinting.Anal Chem2023
37675979Biophysical characterization of PVR family interactions and therapeutic antibody recognition to TIGIT.MAbs2023
35241687Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model.Sci Rep2022
35344340Impact of Drug Conjugation on Thermal and Metabolic Stabilities of Aglycosylated and <i>N</i>-Glycosylated Antibodies.Bioconjug Chem2022
35981087Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab.Cancer Immunol Res2022
35192429Improved therapeutic index of an acidic pH-selective antibody.MAbs2022
35316223Tim-3 mediates T cell trogocytosis to limit antitumor immunity.J Clin Invest2022
34258584Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapy.Blood Cancer Discov2021
33654081Structures of mouse and human GITR-GITRL complexes reveal unique TNF superfamily interactions.Nat Commun2021
33750099Automated and Faster Affinity Capture Method for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.Anal Chem2021
34854675High-Throughput Surface Plasmon Resonance Biosensors for Identifying Diverse Therapeutic Monoclonal Antibodies.Anal Chem2021
34595996Antibody blockade of CD96 by distinct molecular mechanisms.MAbs2021
32178516High-Throughput Platform to Identify Antibody Conjugation Sites from Antibody-Drug Conjugate Libraries.Bioconjug Chem2020
31860282Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies.Anal Chem2020
31856660Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models.MAbs2020
32639723Integrated Approach for Characterizing Bispecific Antibody/Antigens Complexes and Mapping Binding Epitopes with SEC/MALS, Native Mass Spectrometry, and Protein Footprinting.Anal Chem2020
30792442Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates.Sci Rep2019
31700121Author Correction: Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer.Sci Rep2019
31182754Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer.Sci Rep2019
31434693Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma.Mol Cancer Ther2019
29714014Epitope Mapping Using Yeast Display and Next Generation Sequencing.Methods Mol Biol2018
30323890RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models.Oncotarget2018
28060885Antibodies Targeting Closely Adjacent or Minimally Overlapping Epitopes Can Displace One Another.PLoS One2017
28151644Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates.Bioconjug Chem2017
26944918Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design.Mol Cancer Ther2016
26481561Production of soluble and active microbial transglutaminase in Escherichia coli for site-specific antibody drug conjugation.Protein Sci2016
26426339Hemoglobin oxidation at functional amino acid residues during routine storage of red blood cells.Transfusion2016
27582525RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models.Mol Cancer Ther2016
27857134Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoire.Nat Commun2016
27329693The role of MscL amphipathic N terminus indicates a blueprint for bilayer-mediated gating of mechanosensitive channels.Nat Commun2016
27129281Modulation of P2X3 and P2X2/3 Receptors by Monoclonal Antibodies.J Biol Chem2016
27129258Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain.J Biol Chem2016
25284753Precise and efficient antibody epitope determination through library design, yeast display and next-generation sequencing.J Mol Biol2015
26161543Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC Efficacy.PLoS One2015
26154005Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loading.Nat Biotechnol2015
25658443The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity.MAbs2015
25643134Effect of attachment site on stability of cleavable antibody drug conjugates.Bioconjug Chem2015
24423618World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA.MAbs2014
24694238Versatility of microbial transglutaminase.Bioconjug Chem2014
24359082Mass spectrometric characterization of transglutaminase based site-specific antibody-drug conjugates.Bioconjug Chem2014
23438745Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates.Chem Biol2013
23416200Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin.J Mol Biol2013
22019884Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates.J Pharmacol Exp Ther2012
23093611A method for integrative structure determination of protein-protein complexes.Bioinformatics2012
22483106Fabs enable single particle cryoEM studies of small proteins.Structure2012
22543237Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair.J Mol Biol2012
22294692Increasing serum half-life and extending cholesterol lowering in vivo by engineering antibody with pH-sensitive binding to PCSK9.J Biol Chem2012
20837146Three-dimensional molecular modeling with single molecule FRET.J Struct Biol2011
21928778Post-translational modifications and lipid binding profile of insect cell-expressed full-length mammalian synaptotagmin 1.Biochemistry2011
20378544The longin SNARE VAMP7/TI-VAMP adopts a closed conformation.J Biol Chem2010
  • 1 - 50 of 72

Recommended Authors

University of California san francisco
Career Start Year 2015
Number of shared co-authors 1
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2014
Number of shared co-authors 3
The Weizmann Institute of Science
Career Start Year 2007
Number of shared co-authors 1
Genentech Inc.
Career Start Year 2006
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 2004
Number of shared co-authors 2
Janssen Pharmaceuticals
Career Start Year 2003
Number of shared co-authors 1
Merck & Co.
Career Start Year 2003
Number of shared co-authors 2
University of Massachusetts Chan Medical School
Career Start Year 2003
Number of shared co-authors 2
MedImmune Ltd.
Career Start Year 2001
Number of shared co-authors 1
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Career Start Year 2000
Number of shared co-authors 0
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year 1998
Number of shared co-authors 2
College of Science, RMIT University
Career Start Year 1997
Number of shared co-authors 1
Oncology R&D
Career Start Year 1997
Number of shared co-authors 1
Weizmann Institute of Science
Career Start Year 1996
Number of shared co-authors 1
Weizmann Institute of Science
Career Start Year 1995
Number of shared co-authors 1
Technical University of Denmark
Career Start Year 1995
Number of shared co-authors 0
Lilly Research Laboratories
Career Start Year 1994
Number of shared co-authors 2
School of Pharmacy, University of Waterloo
Career Start Year 1993
Number of shared co-authors 2
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
Institute of Microbiology of the CAS
Career Start Year 1991
Number of shared co-authors 1
KTH Royal Institute of Technology
Career Start Year 1990
Number of shared co-authors 0
iHuman Institute, ShanghaiTech University
Career Start Year 1988
Number of shared co-authors 4
Weizmann Institute of Science
Career Start Year 1988
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 3
National Institute of Chemistry
Career Start Year 1988
Number of shared co-authors 1
University of Oxford
Career Start Year 1986
Number of shared co-authors 1
Zuckerman Mind Brain Behaviour Institute
Career Start Year 1982
Number of shared co-authors 1
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Career Start Year 1975
Number of shared co-authors 3
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 1974
Number of shared co-authors 5
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 1

Collaborators

Pfizer Inc.
Co-authored papers 37
Pfizer Inc.
Co-authored papers 19
Pfizer Inc.
Co-authored papers 9
Howard Hughes Medical Institute, California Institute of Technology
Co-authored papers 7
University of Colorado Anschutz Medical Campus
Co-authored papers 4
School of Chemistry & Pharmaceutical Sciences, Guangxi Normal University
Co-authored papers 4
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 3
Albert Einstein College of Medicine
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Harvard Medical School
Co-authored papers 2
Lawrence Berkeley National Laboratory, University of California
Co-authored papers 2
Quantitative Bioscience Institute, University of California san francisco
Co-authored papers 2
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Institute for Biophysical Chemistry, Goethe-University
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers 1
Yale University
Co-authored papers 1
Center for Biomolecular and Cellular Structure, Institute for Basic Science (IBS)
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
UPMC Hillman Cancer Center
Co-authored papers 1
Co-authored papers 1
Joint Center for Structural Genomics
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Korea Advanced Institute of Science and Technology (KAIST)
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
The Hebrew University of Jerusalem
Co-authored papers 1
Harvard Medical School
Co-authored papers 1